SK Co., Ltd. sold 11% of SK Biopharm’s stake to KRW 1,1163 trillion, invested in the entire new growth business
SK, intensive execution of advanced materials, green, bio, and digital businesses… Investment portfolio reorganization
SK, intensive execution of advanced materials, green, bio, and digital businesses… Investment portfolio reorganization
